59Content of authorisation

59 Content of authorisation

(1) A commercial evaluation authorisation must be in writing and include the following (the terms of the authorisation): (a) the proper name for the industrial chemical; (b) the period for which the authorisation is in force (which must not be more than 4 years); (c) the end use for the industrial chemical; (d) that any introduction of an industrial chemical under the authorisation must be for the purposes of commercial evaluation; (e) any conditions relating to the introduction or use of the industrial chemical that are necessary to manage risks to human health or the environment from the introduction or use of the industrial chemical; (f) any specific requirements to provide information to the Executive Director in relation to the introduction; (g) any other information prescribed by the rules for the purposes of this paragraph. (2) The Executive Director must publish the following on the AICIS website in relation to a commercial evaluation authorisation for an industrial chemical: (a) the proper name for the industrial chemical; (b) that a commercial evaluation authorisation is in force for the industrial chemical; (c) the end use for the industrial chemical; (d) the period for which the authorisation is in force.

Note: If an application to treat the proper name or end use for the industrial chemical as confidential business information has been approved, the Executive Director must publish an AACN or generalised end use instead of the proper name or end use if prescribed circumstances apply: see section 109.